Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Organon & Co. | Head of R&D & CMO | Restricted Stock Units | 12.9K | $262K | $20.35 | Nov 7, 2024 | Direct |
Organon & Co. | Head of R&D & CMO | Common Stock | 11.7K | $185K | $15.80 | Nov 7, 2024 | Direct |
Organon & Co. | Head of R&D & CMO | Stock Option (right to buy) | 109K | Mar 29, 2024 | Direct | ||
Myovant Sciences Ltd. | Chief Medical Officer | Common Shares | 0 | $27.00 | Mar 10, 2023 | Direct | |
Myovant Sciences Ltd. | Chief Medical Officer | Performance Stock Unit | 0 | Mar 10, 2023 | Direct | ||
Myovant Sciences Ltd. | Chief Medical Officer | Stock Options (Right to Buy) | 0 | Mar 10, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OGN | Organon & Co. | Nov 7, 2024 | 3 | -$36.3K | 4 | Nov 8, 2024 | Head of R&D & CMO |
OGN | Organon & Co. | Aug 11, 2024 | 3 | -$80.4K | 4 | Aug 12, 2024 | Head of R&D & CMO |
OGN | Organon & Co. | Mar 29, 2024 | 2 | $0 | 4 | Apr 16, 2024 | Head of R&D & CMO |
OGN | Organon & Co. | Jan 1, 2024 | 0 | $0 | 3 | Jan 11, 2024 | Head of R&D & CMO |
MYOV | Myovant Sciences Ltd. | Mar 10, 2023 | 8 | $0 | 4 | Mar 10, 2023 | Chief Medical Officer |
MYOV | Myovant Sciences Ltd. | Jan 18, 2023 | 1 | -$29.8K | 4 | Jan 20, 2023 | Chief Medical Officer |
MYOV | Myovant Sciences Ltd. | Jan 4, 2023 | 1 | -$60.6K | 4 | Jan 5, 2023 | Chief Medical Officer |
MYOV | Myovant Sciences Ltd. | Oct 18, 2022 | 1 | -$40.4K | 4 | Oct 20, 2022 | Chief Medical Officer |
MYOV | Myovant Sciences Ltd. | Oct 4, 2022 | 1 | -$66.8K | 4 | Oct 6, 2022 | Chief Medical Officer |
MYOV | Myovant Sciences Ltd. | Jul 18, 2022 | 1 | -$20.7K | 4 | Jul 20, 2022 | Chief Medical Officer |
MYOV | Myovant Sciences Ltd. | Jul 6, 2022 | 1 | -$36.9K | 4 | Jul 8, 2022 | Chief Medical Officer |
MYOV | Myovant Sciences Ltd. | May 27, 2022 | 1 | -$13.9K | 4 | Jun 1, 2022 | Chief Medical Officer |
MYOV | Myovant Sciences Ltd. | Apr 19, 2022 | 1 | -$48.4K | 4 | Apr 21, 2022 | Chief Medical Officer |
MYOV | Myovant Sciences Ltd. | Apr 15, 2022 | 1 | $0 | 4 | Apr 19, 2022 | Chief Medical Officer |
MYOV | Myovant Sciences Ltd. | Apr 5, 2022 | 1 | -$26.5K | 4 | Apr 7, 2022 | Chief Medical Officer |
MYOV | Myovant Sciences Ltd. | Mar 1, 2022 | 1 | -$18.2K | 4 | Mar 3, 2022 | Chief Medical Officer |
MYOV | Myovant Sciences Ltd. | Jan 4, 2022 | 1 | -$36.9K | 4 | Jan 6, 2022 | Chief Medical Officer |
MYOV | Myovant Sciences Ltd. | Nov 29, 2021 | 1 | -$38.2K | 4 | Dec 1, 2021 | Chief Medical Officer |
MYOV | Myovant Sciences Ltd. | Nov 3, 2021 | 6 | -$61.7K | 4 | Nov 5, 2021 | Chief Medical Officer |
MYOV | Myovant Sciences Ltd. | Oct 5, 2021 | 1 | -$59.2K | 4 | Oct 7, 2021 | Chief Medical Officer |
MYOV | Myovant Sciences Ltd. | Sep 27, 2021 | 3 | -$116K | 4 | Sep 29, 2021 | Chief Medical Officer |
MYOV | Myovant Sciences Ltd. | Aug 27, 2021 | 4 | -$387K | 4 | Aug 31, 2021 | Chief Medical Officer |
MYOV | Myovant Sciences Ltd. | Jul 7, 2021 | 1 | -$60.4K | 4 | Jul 9, 2021 | Chief Medical Officer |
MYOV | Myovant Sciences Ltd. | May 28, 2021 | 4 | -$63.9K | 4 | Jun 2, 2021 | Chief Medical Officer |
MYOV | Myovant Sciences Ltd. | May 26, 2021 | 4 | -$209K | 4 | May 28, 2021 | Chief Medical Officer |